Biotech investors in Belgium
Updated 16 Nov 2026
Venture funds
2 funds, by portfolio companies funded in the last 12 months| # | Fund | Sectors | Stages | Leads | Funded, 12 months |
|---|---|---|---|---|---|
| 1 | Hummingbird Ventures Hummingbird Ventures backs outlier founders globally, recently investing in Etched and Lovable. Brussels, Belgium |
Artificial intelligence, Biotech | Seed, Early stage venture | 28% | 3 |
| 2 | Astanor Ventures Astanor Ventures backs entrepreneurs regenerating food, the blue ocean economy and agriculture, with recent companies BioFluff and Standing Ovation. Luxembourg, Belgium |
Artificial intelligence, Biotech | Seed, Early stage venture, Late stage venture | 55% | 2 |
Table 1. Biotech investors in Belgium: venture capital and micro VC funds ranked by biotech companies whose most recent round closed in the last 12 months. Leads is the share of all recorded investments where the fund was lead investor. Source: FundingWatcher. Data as of 16 November 2026.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Investor | Type | Location | Phone | |
|---|---|---|---|---|
| Gimv | Private equity firm | Antwerp, Belgium | •••@gimv.com | +32 3 ••• |
| Meusinvest (Noshaq) | Venture capital firm | Liège, Belgium | •••@meusinvest.be | +32 (0••• |
| Hummingbird Ventures | Venture capital firm | Brussels, Belgium | •••@hummingbird.vc | +44792••• |
| EIT Digital Accelerator | Startup accelerator | Brussels, Belgium | •••@eitdigital.eu | |
| Bioqube Ventures | Venture capital firm | Hasselt, Belgium | •••@bioqubeventures.com | |
| PMV | Government investment office | Brussels, Belgium | •••@pmv.eu | 02 229••• |
| Capricorn Partners | Venture capital firm | Leuven, Belgium | •••@capricorn.be | +32 (0••• |
| Limburgse Reconversie Maatschappij | Private equity firm | Hasselt, Belgium | •••@lrm.be | +32 11••• |
8 rows of the CSV in 5 of its 15 columns, email and phone masked.
- 12 of the 20 biotech investors in Belgium have a published email address, 9 a phone number and 20 a website.
- European Innovation Council has the most recorded investments, 1,271, 921 of them as lead investor.
- 11 of them are investors in at least one company that closed its most recent round in the last 12 months.
- European Innovation Council is an investor in 17 of those companies, more than any other investor on this list.
- The newest round among their portfolio companies is Onego Bio's $28.0M Series B on 26 October 2026.
- Software is the most common sector across their 349 portfolio companies (64%).
- Early stage venture is the most common investment stage, recorded for 16 of them (80%).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Biotech investors in Belgium
20 of 20, most investments first| # | Investor | Type | Location | Invests in | Latest portfolio companies | Funded, 12 months | Investments | Lead | Exits | Phone | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | European Innovation Council | Startup accelerator | Brussels, Belgium | Hardware, Health care | Onego Bio, Quantrol Ox, Cellbox Solutions | 17 | 1,271 | 921 | 48 | In the CSV | ||
| 2 | EIC Accelerator | Startup accelerator | Brussels, Belgium | Health care, Biotech | Millow.co, D-CRBN, Omegga GmbH | 7 | 543 | 517 | 11 | In the CSV | ||
| 3 | European Commission | Government investment office | Brussels, Belgium | Health care, Artificial intelligence | Healthplus.ai, NVision Quantum Technologies, Geopyörä Oy | 6 | 296 | 204 | 47 | +32 2 ••• | In the CSV | |
| 4 | Gimv | Private equity firm, Venture capital firm | Antwerp, Belgium | Health care, Biotech | SynOx Therapeutics, Kivu Bioscience, Onera Health | 193 | 63 | 64 | •••@gimv.com | +32 3 ••• | In the CSV | |
| 5 | Astanor Ventures | Venture capital firm | Luxembourg, Belgium | Artificial intelligence, Biotech | BioFluff, Standing Ovation | 2 | 75 | 41 | 8 | In the CSV | ||
| 6 | Meusinvest (Noshaq) | Venture capital firm | Liège, Belgium | Health care, Biotech | Amyl Therapeutics | 1 | 74 | 7 | 8 | •••@meusinvest.be | +32 (0••• | In the CSV |
| 7 | Hummingbird Ventures | Venture capital firm | Brussels, Belgium | Artificial intelligence, Biotech | Basecamp Research, Etched, Lovable | 6 | 141 | 39 | 16 | •••@hummingbird.vc | +44792••• | In the CSV |
| 8 | EIT Digital Accelerator | Startup accelerator | Brussels, Belgium | Hardware, Artificial intelligence | Cleafy | 1 | 234 | 6 | 49 | •••@eitdigital.eu | In the CSV | |
| 9 | Bioqube Ventures | Venture capital firm | Hasselt, Belgium | Biotech, Health care | Commit Biologics, SynOx Therapeutics, CatalYm | 17 | 6 | 1 | •••@bioqubeventures.com | In the CSV | ||
| 10 | PMV | Government investment office, Venture capital firm | Brussels, Belgium | Hardware, Health care | Dockflow | 1 | 146 | 34 | 24 | •••@pmv.eu | 02 229••• | In the CSV |
| 11 | Capricorn Partners | Venture capital firm | Leuven, Belgium | Health care, Artificial intelligence | Gradyent, Minze Health, Thryve | 118 | 39 | 32 | •••@capricorn.be | +32 (0••• | In the CSV | |
| 12 | Eurostars | Government investment office | Brussels, Belgium | Health care, Biotech | Alithea Genomics | 1 | 111 | 79 | 12 | In the CSV | ||
| 13 | Limburgse Reconversie Maatschappij | Private equity firm, Venture capital firm | Hasselt, Belgium | Commerce, Education | Hyperfox | 1 | 94 | 13 | 17 | •••@lrm.be | +32 11••• | In the CSV |
| 14 | Qbic Fund | Micro VC fund, Venture capital firm | Ghent, Belgium | Hardware, Biotech | Swave Photonics, Weavely, Flindr Therapeutics | 61 | 18 | 11 | •••@qbic.fund | In the CSV | ||
| 15 | Korys | Family office | Halle, Belgium | Energy, Artificial intelligence | Greenely, OroraTech, Eneida | 44 | 20 | 11 | •••@korys.be | +32 2 ••• | In the CSV | |
| 16 | V-Bio Ventures | Venture capital firm | Ghent, Belgium | Biotech, Health care | Augustine Therapeutics, Flindr Therapeutics | 43 | 16 | 3 | •••@v-bio.ventures | In the CSV | ||
| 17 | Gemma Frisius Fund | Micro VC fund, Venture capital firm | Leuven, Belgium | Biotech, Health care | DName-iT, ArtiQ, Porphyrio | 40 | 5 | 7 | In the CSV | |||
| 18 | Sambrinvest | Venture capital firm | Gosselies, Belgium | Biotech, Fintech | Amyl Therapeutics | 1 | 39 | 4 | 3 | In the CSV | ||
| 19 | UCB Ventures | Corporate venture arm | Brussels, Belgium | Biotech, Health care | EsoBiotec, Walden Biosciences | 19 | 8 | 4 | In the CSV | |||
| 20 | Cascara Ventures | Venture capital firm | Brussels, Belgium | Biotech, Health care | microDimensions, Meidrix Biomedicals | 13 | 1 | 2 | •••@cascaraventures.com | +32 47••• | In the CSV |
Table 2. Biotech investors in Belgium: the first 20 by recorded investments with a website and a location. Email and phone are masked here and complete in the CSV. Source: FundingWatcher. Data as of 16 November 2026. Base: 20.
Most active in the last 12 months
By portfolio companies funded| # | Investor | Location | Funded, 12 months | Portfolio | Latest |
|---|---|---|---|---|---|
| 1 | European Innovation Council | Brussels, Belgium | 17 | 106 | Onego Bio, Quantrol Ox, Cellbox Solutions |
| 2 | EIC Accelerator | Brussels, Belgium | 7 | 36 | Millow.co, D-CRBN, Omegga GmbH |
| 3 | Hummingbird Ventures | Brussels, Belgium | 6 | 22 | Basecamp Research, Etched, Lovable |
| 4 | European Commission | Brussels, Belgium | 6 | 29 | Healthplus.ai, NVision Quantum Technologies, Geopyörä Oy |
| 5 | Astanor Ventures | Luxembourg, Belgium | 2 | 15 | BioFluff, Standing Ovation |
| 6 | Limburgse Reconversie Maatschappij | Hasselt, Belgium | 1 | 11 | Hyperfox |
| 7 | Meusinvest (Noshaq) | Liège, Belgium | 1 | 11 | Amyl Therapeutics |
| 8 | Sambrinvest | Gosselies, Belgium | 1 | 8 | Amyl Therapeutics |
| 9 | EIT Digital Accelerator | Brussels, Belgium | 1 | 48 | Cleafy |
| 10 | Eurostars | Brussels, Belgium | 1 | 6 | Alithea Genomics |
| 11 | PMV | Brussels, Belgium | 1 | 29 | Dockflow |
Table 3. Biotech investors in Belgium: investors in the most companies whose most recent round falls in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Latest rounds in their portfolios
Newest first| Company | What they do | Sector | Location | Last round | Amount | Date | Total raised | Investors on this list | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| Onego Bio | Onego Bio produces egg protein through fermentation as a food ingredient. | Biotech | Helsinki, Finland | Series B | $28.0M | 2026-10-26 | $100.6M | European Innovation Council | 11 to 50 | 2022 |
| Quantrol Ox | QuantrolOx builds machine learning control software that tunes and stabilizes qubits for quantum technologies. | Artificial intelligence | Espoo, Finland | Series A | $13.5M | 2026-10-22 | $21.5M | European Innovation Council | 11 to 50 | 2021 |
| Cellbox Solutions | Cellbox Solutions provides logistics solutions for the global biomedical industry. | Biotech | Cologne, Germany | Series A | $1.7M | 2026-10-20 | $15.3M | European Innovation Council | 11 to 50 | 2017 |
| UniSieve | UniSieve provides molecular separation membrane solutions for cleantech applications. | Energy | Zürich, Switzerland | Series A | $9.0M | 2026-10-08 | $19.7M | European Innovation Council | 11 to 50 | 2018 |
| Basecamp Research | Basecamp Research is a biotechnology company that uses AI and biological data to develop therapeutics. | Artificial intelligence | London, United Kingdom | Series C | $140.0M | 2026-09-23 | $219.9M | Hummingbird Ventures | 51 to 100 | 2019 |
| Treble | Treble develops acoustic simulation technology for designing sound in architecture, audio, robotics, automotive, XR, and gaming. | Artificial intelligence | Reykjavík, Iceland | Series A | $18.0M | 2026-09-17 | $40.3M | European Innovation Council | 11 to 50 | 2019 |
| Healthplus.ai | Healthplus.ai uses AI to predict post-operative infection risks for surgical patients. | Artificial intelligence | Amsterdam, The Netherlands | Seed | $3.8M | 2026-09-03 | $8.9M | European Commission | 11 to 50 | 2017 |
| BioFluff | BioFluff creates plant-based fur, shearling, and plush for the fashion, interior, and toy industries. | Biotech | Paris, France | Seed | $2.5M | 2026-09-02 | $3.2M | Astanor Ventures | 1 to 10 | 2022 |
| Amyl Therapeutics | Amyl Therapeutics is a preclinical biotechnology company developing immunotherapy for neurodegenerative diseases. | Biotech | Liège, Belgium | Series A | $9.6M | 2026-09-01 | $44.0M | Meusinvest (Noshaq), Sambrinvest | 1 to 10 | 2020 |
| Etched | Etched designs and manufactures AI chips and hardware systems for inference workloads. | Artificial intelligence | San Jose, United States | Series D | $700.0M | 2026-08-18 | $1.6B | Hummingbird Ventures | 251 to 500 | 2022 |
Table 4. Biotech investors in Belgium: the 10 most recent rounds of companies they back. Source: FundingWatcher. Data as of 16 November 2026.
Portfolio sectors
| Portfolio sectors | Companies | Share |
|---|---|---|
| Software | 225 | 64% |
| Health care | 102 | 29% |
| Hardware | 92 | 26% |
| Artificial intelligence | 86 | 25% |
| Biotech | 75 | 21% |
| Energy | 23 | 7% |
| Commerce | 15 | 4% |
| Fintech | 13 | 4% |
| Education | 12 | 3% |
| Cybersecurity | 12 | 3% |
Table 5. Biotech investors in Belgium: portfolio companies by sector. Source: FundingWatcher. Data as of 16 November 2026.
Investment stages
| Investment stages | Investors | Share |
|---|---|---|
| Early stage investors | 16 | 80% |
| Seed investors | 14 | 70% |
| Late stage investors | 6 | 30% |
| Venture investors | 6 | 30% |
| Grant makers | 5 | 25% |
| Private equity investors | 3 | 15% |
| Convertible note investors | 3 | 15% |
| Secondary market investors | 2 | 10% |
Table 6. Biotech investors in Belgium by stage they invest at. Source: FundingWatcher. Data as of 16 November 2026.
Cities
Table 7. Biotech investors in Belgium by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.
Founded
| Founded | Investors | Share |
|---|---|---|
| 2010s | 9 | 45% |
| 2000s | 1 | 5% |
| 1990s | 3 | 15% |
| 1980s | 4 | 20% |
| 1950s | 3 | 15% |
Table 8. Biotech investors in Belgium by founding decade. Source: FundingWatcher. Data as of 16 November 2026.
Method
- An investor is on this list when it is recorded as an investor in 2 or more funded biotech companies and its headquarters is in Belgium. On 16 November 2026 that is 20 investors.
- 12 rows carry an email address and 9 a phone number from the investor file. Investments, lead investments and exits are the counts the source records.
- The table prints the first 20 rows by recorded investments that carry a website and a location, with email and phone masked. The CSV carries all 20 rows: 0 have no website and 0 no location.
Sources, fields and exclusions of both files: Method.
Questions
- How many biotech investors in Belgium are on the list?
- 20, in the file dated 16 November 2026. 11 of them invested in a company whose most recent round falls in the last 12 months.
- How many have an email address?
- 12 of the 20 carry an email address in the download and 9 a phone number.
- What does the CSV contain?
- One row per investor, 15 columns: name, types, stages, city, region, country, founded, website, linkedin, investments, funded_last_12m, exits, lead_investments, email, phone.
- How much does the list cost?
- $29 one-time for all 20 rows, no account. Every investor and every startup, two files, cost $99. With partner contacts, up to 2 per firm compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV with 20 rows, 12 firm email addresses and 9 phone numbers, on the page after payment and by mail. The emails are the address a firm publishes: 10 of the 12 are inboxes such as info@ or contact@. No partner names.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.